| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $236K | -95.1% |
| R&D Expense | $36.9M | -4.0% |
| SG&A Expense | $20.9M | -9.1% |
| Operating Income | -$57.6M | -1.6% |
| Interest Expense | $3.6M | +12.0% |
| Net Income | -$59.9M | +1.3% |
| EPS (Basic) | -$6.31 | +42.0% |
| EPS (Diluted) | -$6.31 | +42.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.7M | -61.3% |
| Short-term Investments | $82.1M | +48.7% |
| Current Assets | $96.5M | +6.7% |
| Total Assets | $124.3M | -0.3% |
| Current Liabilities | $19.6M | +18.1% |
| Long-term Debt | $20.4M | -5.1% |
| Total Liabilities | $57.5M | -11.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$51.0M | -13.2% |
| Capital Expenditures | $96K | -50.8% |
| Investing Cash Flow | -$24.5M | -162.4% |
| Financing Cash Flow | $54.9M | +163.2% |
| Free Cash Flow | -$51.1M | -13.0% |
| Stockholders' Equity |
| $66.8M |
| +12.2% |